1 / 13

Solumbra Technique for Mechanical Thrombectomy

#DelveInsight estimates that Solumbra Technique is set to occupy substantial NeurovascularThrombectomy Devices market share, which is expected to rise by 2026. It is expected that Medtronicu2019s Solumbra will take around 40% of the market share. However, it will face stiff competition from other players such as Stryker, Perflow Medical, Johnson & Johnson, Acandis GmbH, MicroVention-Terumo, and many others.<br><br>Get in touch to know what factors are responsible for Solumbrau2019s success in the market and how it will impact the Neurovascular Thrombectomy Devices market in the future at info@delveinsight.

31809
Download Presentation

Solumbra Technique for Mechanical Thrombectomy

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Analysis by DelveInsight SOLUMBRA Is it a better choice for Mechanical Thrombectomy?

  2. Stroke & Burden 795,000 87% 16% DEATHS Accordingtothe CentersforDisease Controland Prevention (CDC), morethan795,000 peopleintheUnited Statessufferfroma strokeeveryyear. Ofallstrokesare ischemicstrokes. Itis oneofthesignificant causesofdeath worldwideandadds totheburdenofthe healthcaresystemas well. AsperWHOtheworld's biggestkillerisischemic heartdisease, leadingto 16% oftheworld'stotal deaths, followedby stroke (11%) & COPD (6%).

  3. TREATMENT MODALITIES The Treatment Algorithm Mentionedinthe2019, GuidelinesfromtheAmericanHeartAssociation/AmericanStroke Association, statesthatanticoagulantssuchas intravenous (IV) tissue plasminogen activator (tPA) shouldbeadministeredtoalleligibleacutestrokepatientswithin3 hours of the stroke. Moderate Categories. Thecaveathereisthatnotmanypeopleareabletoaccesstreatmentthisearlyafter sufferingfromstroke, consideringmostofthemmayfallinthemildandmoderate categories. Thrombectomy Devices Aftermanyground-breakingclinicalstudies, ithasbeenfoundthatthrombectomy deviceshavebetteroutcomeswhenusedincombinationwitht-PA, versust-PAalone andcanbeusedasstandardstroketreatment.

  4. What is it? Solumbra Technique isonesuchprocedure thatusesastentandanaspirationretriever simultaneouslyandconfirmstheremovalof thrombusfragmentsduringstentretrieval. Itinvolvedplacementofastentretriever, suchasSolitaire, Trevo, orMindframe, distalto theclotwithanintermediatecatheter, such as 5 Max Ace, Ace 64, or SOFIA, at the clot face. Solumbra Technique

  5. TheSolumbraTechniqueemployeesalongsheaththatissentto thedistalcervicalsegmentoftheinternalcarotidartery (ICA) orthe vertebralarteryusinganexchangetechniqueundergeneralorlocal anesthesia, anda 0.025-inch microcatheter (Rebar27, Medtronic Neurovascular)harboringa0.016-inchmicro-guidewirewas introducedintoalarge-boreaspirationcatheter (ACE, Penumbra; or theSOFIA, MicroVentionTerumo). Composition Thesewereallnavigatedintothelongsheathasaunit, andthelarge- boreaspirationcatheterwassenttotheproximalendofthethrombus ascloseaspossiblebeforedeploymentoftheSolitaireFRstent-retriever (MedtronicNeurovascular) acrossthethrombusthroughthe microcatheter. Afterthis, themicrocatheterwasremovedentirely, andthreetofive minutes later,thelargeaspirationcatheterwasconnectedfor continuousaspirationwhileadvancingtheaspirationcathetertothe proximalendofthethrombusascloseaspossible.

  6. Benefits BETTER FIRST-PASS EFFECTS MINIMAL RISKS AND SIDE EFFECTS FEWER STENT PASSAGES REDUCE THE RISK OF PROCEDURE-RELATED COMPLICATIONS, SUCH AS PARENCHYMAL HEMATOMA AND OTHER VESSEL DAMAGE THE RADIOPAQUE FEATURES OF THE DEVICE LET THE INTERVENTIONALISTS VIEW THE ENTIRE STENT AND CONFIRM ITS OPTIMAL LOCATION AND ADEQUATE VESSEL-WALL APPOSITION OF THE STENT

  7. Stentriever Neurovascular Thrombectomy Techniques Aspiration Solumbra

  8. Market Valuation DelveInsight'sanalysisinthereporttitled, DelveInsight's Neurovascular Thrombectomy Devices Market Insights, Competitive Landscape and, Market Forecast - 2026, demonstratesthatthecombinationtherapy, whichusesbothaspirationscombinedwith stentretrieverssuchasSOLUMBRA, will take up more market share in the future. $172.67 Million ThemarketshareoftheSolumbraTechniqueis estimatedtoincreaseby2026, takingaround 40% of the market share. Market Drivers Increase in patient share Increase in acceptance rate Better treatment course Promising efficacy of the technique Technological advancements Positive results of clinical trials

  9. Impact of COVID TheCOVID-19impactedthe neurovascularthrombectomydevices heavilyin2020, andthemarketsawa steepdeclinein2020. Dueto nationwidelockdownsineverycountry, marketaccesswasatahigh-timelow. Still, themarketisexpectedtorecover from2021andincreaseovertheyears till2026.

  10. Competitors in the Market Thetechniquewillfacecompetitionfromotherdevices, includingaspirationcatheters, stentretrievers, ADAPT techniques, etc. Fogarty arterial embolectomy catheter (Edward LifeSciences Corporation), the Penumbra System (Penumbra), and PRIORITYONE Aspiration Catheter (Terumo Corporation)aresomeoftheneurovascular thrombectomydevicesinthemarket.

  11. Market Forecast Themarketforneurovascular thrombectomydevicesisestimatedto increaseduetoincreaseinincidenceand prevalenceofneurovasculardiseases, advancementsinhealthcaretechnology, highhealthcareexpenditure, and availablereimbursementpoliciesin thedevelopedcountries.

  12. Wondering? How much Market Share your Medical Device is Going to Capture? What should be your Go-To Market Strategy? Do you need help with the Pricing of the Product? How can you Navigate Commercial Hurdles? Do you need Opinions from Industry Experts? Do you need to Understand End-Users and Market Trends? Schedule a call with DelveInsight's Medical Device Consulting Team and get your answers! Contact us : info@delveinsight.com

  13. Related Reports Neurovascular Devices/Interventional Neurology Market Insights, Competitive Landscape and Market Forecast - 2026 Neurovascular Coiling Assist Devices -Market Insights, Competitive Landscape and Market Forecast - 2025 Choroidal Neovascularization Market Insights, Epidemiology, and Market Forecast-2030

More Related